Advertisement

Topics

Latest "important process fueling harmful algal blooms investigated Canadian" News Stories

02:07 EDT 25th June 2018 | BioPortfolio

Here are the most relevant search results for "important process fueling harmful algal blooms investigated Canadian" found in our extensive news archives from over 250 global news sources.

More Information about important process fueling harmful algal blooms investigated Canadian on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about important process fueling harmful algal blooms investigated Canadian for you to read. Along with our medical data and news we also list important process fueling harmful algal blooms investigated Canadian Clinical Trials, which are updated daily. BioPortfolio also has a large database of important process fueling harmful algal blooms investigated Canadian Companies for you to search.

Showing "important process fueling harmful algal blooms investigated Canadian" News Articles 1–25 of 19,000+

Monday 25th June 2018

New Imeglimin Data Demonstrating Pancreatic Beta-Cell Protection Presented at the American Diabetes Association 78th Scientific Sessions

Imeglimin was observed to protect and preserve human beta-cells from cell death from fructose- and glucose-induced toxicity by inhibiting mitochondrial Permeability Transition Pore opening (mPTP) Preclinical data highlights Imeglimin’s potential to delay type 2 diabetes disease onset and progression through the preservation of ...


Sunday 24th June 2018

Funding competition - Establishing a UK vaccines development and manufacturing centre

UK-based organisations can apply for up to £66 million to build and establish a national vaccines development and manufacturing centre. Competition opens: Thursday 12 October 2017 Registration closes: Wednesday 15 November 2017 12:00pm Description Innovate UK is to invest up to £66 million capital funding to build and establish a good manufacturing practice (GMP) capable UK national va...

Clostridium difficile infections have decreased 36 percent in Canadian hospitals

(Canadian Medical Association Journal) Rates of C. difficile infections have decreased 36 percent in hospitals across Canada, although the virulent NAP1 strain associated with severe illness and deaths is the most common strain, according to research published in CMAJ (Canadian Medical Association Journal).


26th GERRY WEBER OPEN 2018: The Perfect Fusion of Fashion and International Tennis

"Game, set, and match" was once again the motto at Germany'smost important ATP 500 grass court event, the "GERRY WEBER OPEN", named after the Read more...

Chapter House Counseling Center Launches Partial Hospitalization Program

Chapter House a counseling center in North Dallas providing addiction recovery services launches partial hospitalization program for people with substance use disorders. DALLAS, Texas (PRWEB) June 24, 2018 Chapter House Counseling Center has launched a Substance Abuse Partial Hospitalization Program (PHP) in the North Dallas city of Richardson, Texas. This increase in services comes after 3 ½...

For Kids, Summer Is Time for Other Types of Learning

SUNDAY, June 24, 2018 -- It's important for children to socialize during their summer holidays, a family medicine and psychiatry expert says. "Kids deserve a break during the summer. They've worked hard during the school year and this is their time...

Saturday 23rd June 2018

Fisher-Rosemount Upgrades DeltaV Software

The DeltaV process control and management system has been updated with features that extend its utility for batch processors...

New Manufacturing Process Spins Ceramic Fibers More Safely

Researchers at the University of Warwick Process Technology Group (Coventry, England; (+)44-120-352-4200) have devised a technique for manufacturing spun-fiber based ceramics...

Survey demonstrating underuse of glucagon rescue kits in type 1 diabetes patients to be presented at the ADA's 78th Scientific Sessions

Press Release - No. 16/2018 Survey demonstrating underuse of glucagon rescue kits in type 1 diabetes patients to be presented at the ADA's 78th Scientific Sessions T1D Exchange and Dr. Morey Haymond, MD, to present a Zealand Pharma supported survey of use of glucagon rescue kits by type 1 diabetes patients and caregivers Results demonstrate underuse of glucagon res...

Joslin Diabetes Center, The American Journal of Managed Care® Collaborate to Publish Clinical Guidelines

Clinical guidelines that direct care at Joslin Diabetes Center, the world-renowned institution for diabetes treatment, research, and education, are now published in Evidence-Based Diabetes Management™, a publication of The American Journal of Managed Care® The American Journal of Managed Care® has published core clinical guidelines from Josl...

Sunovion Presents Data from Pivotal Phase 3 Study of Apomorphine Sublingual Film (APL-130277) at the 2nd Pan American Parkinson’s Disease and Movement Disorders Congress

- Data shows apomorphine sublingual film has superior efficacy versus placebo for the on-demand treatment of OFF episodes associated with Parkinson’s disease - Sunovion Pharmaceuticals Inc. (Sunovion) today presented the positive results of its pivotal, Phase 3, randomized, double-blind, placebo-controlled trial, CTH-300. This study evaluated ...

Compelling Data for LONSURF® (trifluridine/tipiracil) in Metastatic Colorectal Cancer Presented at ESMO’s World Congress on Gastrointestinal Cancer by Servier and Taiho

Phase II TASCO-1 trial demonstrates promising progression-free survival results in previously untreated patients Phase IIIb PRECONNECT study provides further efficacy and safety data for LONSURF® in previously treated patients Servier and Taiho Pharmaceutical Co., Ltd. today announced that the TASCO-1 trial ...

Friday 22nd June 2018

ALK and ROS1 Clones from CST Featured in Latest Guidelines for the Diagnosis and Treatment of Non-Small Cell Lung Cancer

Two Cell Signaling Technology antibody clones, ALK (D5F3®) and ROS1 (D4D6®), were featured in an article authored by the Tumor Biomarker Experts of the Chinese Society of Clinical Oncology. The article, Guidelines for diagnosis and treatment of ALK and ROS1 positive non-small cell lung cancer in China, was published in the April 8th, 2018 edition of the Chinese Journal of Pathology, and ...

Sinusitis - A Pipeline Analysis Report 2018 | Technavio

Technavio has announced its latest pipeline analysis report on the sinusitis market. The report includes a detailed analysis of the pipeline molecules under investigation within the defined data collection period to treat chondrosarcoma. This press release features multimedia. View the full release here: https://www.businesswire.com/new

Rabies - A Pipeline Analysis Report 2018| Technavio

Technavio has announced its latest pipeline analysis report on the rabies market. The report includes a detailed analysis of the pipeline molecules under investigation within the defined data collection period to treat chondrosarcoma. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180622005663/en/

Firing Line with Margaret Hoover Premieres Nationwide on PBS Stations Beginning Tonight, ...

Margaret Hooverbrings together the brightest minds and freshest voices from across the political spectrum to engage in a contest of ideas about important issues Read more...

Four Student Teams Named National Winners of 2017-18 eCYBERMISSION Competition

The U.S. Army Educational Outreach Program (AEOP) is pleased to announce the 2017-18 national winners of the 16th annual eCYBERMISSION competition. The winning teams were announced today at the National Judging & Educational Event (NJ&EE) awards luncheon in Reston, Virginia. The web-based science, technology, engineering and math (STEM) pr...

Zur Rose Group AG successfully issues a public bond of CHF 85 million

EQS Group-News: Zur Rose Group AG / Key word(s): Bond 22.06.2018 / 17:44 Press release NOT FOR DISTRIBUTION IN THE UNITED STATES Zur Rose Group AG successfully issues a public bond of CHF 85 million Today, Zur Rose Group AG successfully placed a CHF 85 million public bond. The bond offers a coupon of 2.50% and has a tenor of 5 years. The bond will be settled on 19 July 2018 following i...

JAK Inhibitors for Lung Cancer | A Pipeline Analysis Report 2018 | Technavio

Technavio has announced their latest pipeline analysis report on the JAK inhibitors for lung c

Aetna Wins Contract for Kansas Medicaid Program

The State of Kansas notified Aetna (NYSE: AET) that it has awarded a Medicaid managed care contract to Aetna Better HealthSM of Kansas. Starting on January 1, 2019, Aetna Better Health of Kansas will offer Medicaid benefits to enrollees statewide in the KanCare Medicaid managed care program. KanCare serves parents, pregnant women and

Liberals and conservatives imagine the face of God differently, psychologists find

Susan Perry The image of God that American Christians hold in their mind looks nothing like the rather stern, bearded old white man painted by Michelangelo (or, for that matter, the one depicted by Monty Python).Instead, American Christians tend to imagine God as being younger and kinder. And, depending on their political bent, they may also...

BIOQuébec and Triumvirate Environmental Join Forces to Promote and Facilitate the Implementation of Effective and Sustainable Laboratory Practices

BIOQuébec and Triumvirate Environmental are pleased to announce they have finalized a collaboration agreement aiming to promote access for BIOQuébec members to products and services that will allow them to implement and maintain safe and sustainable laboratory practices. “As a BIOQuébec partner, we are proud to contribute to the development o...

Cannabidiol: Does It Help in Drug-resistant Epileptic Encephalopathies?

In this double-blind, placebo-controlled trial, the authors investigated the efficacy of adjunctive cannabidiol in a population of severe developmental epileptic encephalopathies and found some efficacy.

Ross University School of Medicine Celebrates its 40-year Anniversary on June 23, 2018

Established in 1978, Ross University School of Medicine (RUSM) was launched with 11 initial students. Today, RUSM has more than 14,000 diverse alumni practicing medicine across the United States. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180622005310/en/ RUSM was originally named the Univers...

vTv Therapeutics to Present a Poster at the American Diabetes Association’s 78th Scientific Sessions

vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical-stage biopharmaceutical company engaged in the discovery and development of new orally administered treatments for Alzheimer’s disease, diabetes and other therapeutic areas, today announced that Company management will present a poster featuring vTv Therapeutics’ liver-selective Glucokinase Activator at ...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks